Dr Hengrui Liu

YEAR STARTED

2026

SUBJECT

Biomedical

FELLOW TYPE

Postdoctoral By-Fellows

Dr Hengrui Liu is a Research Associate at the Early Cancer Institute, Department of Oncology, University of Cambridge, where he develops liquid biopsy technologies for the early detection and monitoring of cancer and chronic liver disease. His research combines cancer genomics, cell-free DNA biology, fragmentomics and computational methods to better understand disease evolution and improve precision diagnostics.

Before joining the Early Cancer Institute, Hengrui completed his PhD in Biochemistry at the University of Cambridge. His current work focuses on understanding the biological mechanisms underlying circulating DNA and translating these discoveries into clinically applicable biomarkers. He also collaborates with clinicians and researchers across the UK and internationally on projects spanning cancer early detection and precision medicine.

Alongside his research, Hengrui is actively involved in scientific publishing and serves as an editor for several international journals in oncology and biomedical sciences. As a Churchill By-Fellow, he looks forward to contributing to the College through interdisciplinary collaboration, mentoring and undergraduate teaching.